Concepedia

Elizabeth M. Naylor

EM

Statistics

Publications

14

Citations

414

H-Index

13

Active since

1994

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Johns Hopkins University

Elizabeth M. Naylor is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicinal chemistry, and receptor pharmacology.

Publications per year

1994–2002

14

Publications

14

A Highly Potent, Orally Active Imidazo[4,5-b]pyridine Biphenyl Acylsulfonamide (MK-996; L-159,282): A New AT1-Selective Angiotensin II Receptor Antagonist

Prasun K. Chakravarty, Elizabeth M. Naylor, Anna Chen et al. · Journal of Medicinal Chemistry · 1994 · 53 citations · Full text

, , +6

Human β3 andrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamides

Elizabeth M. Naylor, Emma R. Parmee, Vincent J. Colandrea et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 46 citations · Full text

, , +7

Triazolinone Biphenylsulfonamide Derivatives as Orally Active Angiotensin II Antagonists with Potent AT1 Receptor Affinity and Enhanced AT2 Affinity

Wallace T. Ashton, Linda Chang, Kelly L. Flanagan et al. · Journal of Medicinal Chemistry · 1994 · 37 citations · Full text

, , +12

3-pyridylethanolamines: Potent and selective human β3 adrenergic receptor agonists

Elizabeth M. Naylor, Vincent J. Colandrea, Mari R. Candelore et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 34 citations · Full text

, , +5

Synthesis and regioselective alkylation of 1,6- and 1,7-naphthyridines

Vincent J. Colandrea, Elizabeth M. Naylor · Tetrahedron Letters · 2000 · 33 citations

, , +7

1–5 of 14